EPCAM and neoplasm: Immunostaining of β‐catenin, EGFR, and EpCAM confirmed that these proteins were highly expressed in the Nr2e3−/− tumor tissues at 24‐week (Figure 3G) and 48‐week time points (Figure S8B, Supporting Information).